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Summary 
 
Local translation regulates the axonal proteome, playing an important role in neuronal wiring 
and axon maintenance. How axonal mRNAs are localized to specific subcellular sites for 
translation, however, is not understood. Here, we report that RNA granules associate with 
endosomes along the axons of retinal ganglion cells. RNA-bearing Rab7a-late endosomes 
also associate with ribosomes, and real-time translation imaging reveals that they are sites of 
local protein synthesis. We show that RNA-bearing late endosomes often pause on 
mitochondria and that mRNAs encoding proteins for mitochondrial function are translated on 
Rab7a-endosomes. Disruption of Rab7a function with Rab7a mutants, including those 
associated with Charcot-Marie-Tooth type 2B neuropathy, markedly decreases axonal 
protein synthesis, impairs mitochondrial function and compromises axonal viability. Our 
findings thus reveal that late endosomes interact with RNA granules, translation machinery 
and mitochondria, and suggest that they serve as sites for regulating the supply of nascent 
pro-survival proteins in axons. 
 
Introduction 
 
Local translation of mRNAs is a highly conserved mechanism that allows the spatial and 
temporal control of the proteome at a subcellular level (Martin and Ephrussi, 2009). This 
regulation is particularly important in neurons where tight control of protein localization allows 
highly compartmentalized functions far from the cell soma (Holt and Schuman, 2013; 
Terenzio et al., 2017). mRNAs made in the nucleus associate directly with RNA-binding 
proteins (RBPs) (Andreassi and Riccio, 2009; Xing and Bassell, 2013) and are transported 
as ribonucleoprotein particles (RNPs) to distal subcellular locations for local translation 
(Eliscovich and Singer, 2017; Mitchell and Parker, 2014; Xing and Bassell, 2013). However, 
the mechanisms regulating precise RNP localization and nascent protein synthesis at 
defined neuronal sites remain largely unknown. 
 
The endosomal pathway has been implicated in mRNA localization and translation in the 
fungus, Ustilago maydis, where the polarized growth of long hyphae requires the endosomal-
dependent transport of the RBP, Rrm4, and the translation of its cargo septin mRNA 
(Baumann et al., 2014). In neurons, membrane trafficking relies on endosomes, which carry 
a range of proteins and lipids for targeted delivery (Cosker and Segal, 2014; Lasiecka and 
Winckler, 2011). The endosomal pathway internalizes cargos from the cell surface, regulates 
their storage and their recycling, or sends them to lysosomes for degradation (Huotari and 
Helenius, 2011). In addition to their role in trafficking, endosomes operate as platforms where 
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diverse intracellular signaling cascades can be activated or sustained (Villasenor et al., 
2016). Two of the main players of this endosomal system are the early and late endosomes 
that can be distinguished by their associated Rab GTPases (Stenmark, 2009): Rab5 
coordinates clathrin-dependent endocytosis, biogenesis of early endosomes and their fusion, 
while Rab7 regulates the transport and maturation of acidic late endosomes, as well as their 
fusion with lysosomes. 
 
Here we show that RNPs associate with motile Rab7a-endosomes along retinal ganglion cell 
(RGC) axons. RNP-bearing Rab7a-endosomes frequently dock at mitochondria where they 
serve as hotspots for de novo protein synthesis. Disruption of Rab7a function by expression 
of Charcot-Marie-Tooth disease type 2B (CMT2B)-linked Rab7a mutants leads to impaired 
local protein synthesis, mitochondrial dysfunction and loss of axon integrity. 
 
Results 
 
RNA granules are associated with endosomes in axons 
RNA-binding proteins and ribosomes associate with motile endosomes in fungal hyphae 
(Baumann et al., 2014; Higuchi et al., 2014), raising the possibility that endosomes are 
involved in RNA granule trafficking in other cell types with elongated profiles, such as 
vertebrate neurons. To visualize the movement of RNPs in the axons of Xenopus RGCs, we 
labeled endogenous RNAs by blastomere injection of the fluorescently labeled uridine-5’-
triphosphate (Cy3-UTP). Cy3-UTP is incorporated into RNAs during synthesis, including 
rRNAs and mRNAs (Wong et al., 2017), allowing the subsequent visualization of fluorescent 
Cy3-RNA granules in RGC axons of cultured embryonic eyes (Figure 1A). Single particle 
tracking analysis revealed the presence of static/oscillatory (Figure 1B1), slow-moving 
(Figure 1B2) and fast-moving (Figure 1B3) states of RNA granule movements, with 
occasional switches from one state to another. Most Cy3-RNA granules displayed 
static/oscillatory motions over 2 minutes (Figure 1C), similar to single mRNAs in dendrites 
(Yoon et al., 2016). A slight bias towards anterograde compared to retrograde transport 
(Figure 1C) is consistent with the directional movements of Neurofilament-Light (Nefl) mRNA 
in axons (Alami et al., 2014). The speed distribution of transported RNA granules could be 
resolved into two classes of anterograde or retrograde transport: slow and fast (Figure 1D), 
as observed for endogenous β-actin mRNA in axons (Turner-Bridger et al., 2018). The 
average speed of individual Cy3-RNA granules was negatively correlated with their signal 
intensities suggesting that slow-moving or static granules can carry a larger RNA cargo load 
(Figure 1E). 
 
 4 
To ask if RNA granules in axons are associated with endosomes, we used GFP-Rab5a or 
GFP-Rab7a which label early and late endosomes, respectively (Falk et al., 2014) (Figures 
S1A-D). Both exhibited typically rounded profiles, with occasional variations in size and 
shape indicative of different endosomal maturation/fusion states. By expressing GFP-Rab5a 
and GFP-Rab7a along with Cy3-labeled RNAs, we found that static/oscillatory and moving 
Cy3-RNA granules were often associated with both early and late endosome reporters in 
axons (Figures 1F and 1G, Movie S1). RNA granules appeared to associate and dissociate 
from endosomes (Figure 1G), a characteristic similar to that observed for RNPs in fungal 
hyphae (Higuchi et al., 2014). Cy3-RNA granules were preferentially associated with GFP-
Rab7a (40±3%, N=298 RNA granules analyzed in 23 axons) compared to GFP-Rab5a 
(24±1%, N=347 RNA granules analyzed in 24 axons). Despite the abundance of 
endoplasmic reticulum (ER) throughout the axon, the levels of co-labeling between Rab5a/7a 
endosomes and ER was comparatively low (Figures S1C-D) and dynamic co-imaging 
showed that Cy3-RNA granules moved independently of the ER (Figure S1E). 
Static/oscillatory movements were most prevalent among RNA granules associated with 
Rab5a- or Rab7a-endosomes (Figure 1H). Furthermore, RNA granules associated with GFP-
Rab5a- or GFP-Rab7a-endosomes moved significantly slower than isolated RNA granules in 
the same axons (Figure 1I). The average pixel intensity and the size of endosome-
associated Cy3-RNA granules were higher and larger than isolated Cy3-RNA granules, 
suggesting the presence of more RNA (Figures 1J and 1K). 
 
We next asked whether Rab activity plays a role in global RNA granule trafficking in RGC 
axons. Expression of constitutively active (CA) or dominant negative (DN) forms of Rab5a, 
but not Rab7a, induced a visible reduction in axonal growth as previously reported (Falk et 
al., 2014). However, expression of mutant forms of either Rab5a or Rab7a did not affect the 
RNA granule speed distribution profile or directionality compared to controls (Figures S2A-
D).  
 
Collectively, these results suggest that while RNA granules are mostly transported and 
distributed in axons in an endosome-independent manner, they frequently associate with 
both early and late endosomes along the axon and exhibit slow or static/oscillatory 
movements (Figure S2E). 
 
Ribosomes, RNA-binding proteins and mRNAs localize to endosomes in axons 
Previous mass spectrometry analysis of endosomal composition in neurons revealed the 
presence of RNA-binding proteins and translation machinery (Debaisieux et al., 2016). We 
therefore performed immunocytochemistry against known RNP components in RGC axons 
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(Cioni et al., 2018; Leung et al., 2006). Rab5, Rab7 and the late endosome marker LAMP-1 
partially colocalized with RNA-binding proteins, such as Vg1RBP (zipcode-binding protein-1) 
or Xenopus RNA binding protein Fragile X-related (FXR), as well as ribosomal proteins in 
axon shafts (Figures 2A and 2B).  
 
To study these associations in more detail, we analyzed ribosomal proteins, Vg1RBP and its 
β-actin mRNA cargo (Leung et al., 2006; Welshhans and Bassell, 2011) in live imaging. 
Ribosomal proteins, Vg1RBP and β-actin mRNA each associate with GFP-tagged Rab5a 
and Rab7a proteins using immunoprecipitation (IP) assays (Figures S3A and S3B), and 
super-resolution microscopy revealed that ribosomal proteins closely associated with GFP-
Rab5a- and GFP-Rab7a-endosomes (Figure S3C). Ribosomal protein RPS3A-GFP exhibited 
a mostly diffuse pattern of fluorescence interspersed with foci of higher intensity along the 
axon shaft. Live co-imaging of RFP-Rab5a, RFP-Rab7a, LAMP-1-RFP and RPS3A-GFP 
revealed an association between the ribosomal and endosomal markers (Figure 2C, Movie 
S2), which exhibited coordinated motions, mostly oscillatory or static, that persisted 
throughout the 1-minute imaging period (Figure 2D). Similar results were obtained by co-
expressing another ribosomal protein, RPS4X-GFP, with RFP-Rab5a or RFP-Rab7a (Figure 
S3D). Although a majority of the GFP-Vg1RBP signal was not co-transported with 
endosomes, we found that a fraction of GFP-Vg1RBP also joined slow-moving endosomes 
over the 1-minute recording periods (Figures 2E and 2F, Movie S3) and displayed 
static/oscillatory motions (Figure 2G). To track endogenous β-actin mRNA directly, we used 
Cy3-molecular beacons (MBs) (Turner-Bridger et al., 2018). MBs are hairpin-shaped 
oligonucleotide probes with a fluorophore and a quencher that separate upon hybridization to 
target sequences (Alami et al., 2014), allowing the visualization of endogenous transcripts. 
MB tracking revealed that approximately 25% and 35% of β-actin mRNA granules were, 
indeed, associated with GFP-Rab5a and GFP-Rab7a (Figures 2H and 2J), of which most 
were static/oscillatory (Figure 2I). Together, these results indicate that ribosomes, RNA-
binding proteins and mRNAs frequently assemble together with endosomes in axons. 
 
Late endosomes are sites of intra-axonal protein synthesis 
Static RNA granules labeled with fluorescent UTPs are hotspots of newly synthesized 
proteins in axon terminals in vivo (Wong et al., 2017). Our findings above raise the possibility 
that these hotspots are on endosomes. To test this idea, we first investigated whether de 
novo protein synthesis in RGC axons is affected by altered Rab function. Axon-only cultures 
(after soma removal) were pulse-labeled with a low concentration of puromycin (2µM), a 
structural analogue of aminoacyl-tRNAs, which incorporates into the carboxyl termini of 
nascent polypeptide chains. Puromycylated peptides can be recognized by anti-puromycin 
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antibodies (puro-signal) allowing quantification of local protein synthesis (Schmidt et al., 
2009). We found a significant reduction of puro-signal in growth cones expressing CA mutant 
GFP-Rab7aQ67L (0.74±0.03) or DN mutant GFP-Rab7aT22N (0.81±0.04), but not wild-type 
GFP-Rab7a, wild-type GFP-Rab5a, CA mutant GFP-Rab5aQ80L or DN mutant GFP-
Rab5aS35N (Figures 3A and 3B). Next, we acutely perturbed endosomal sorting 
pharmacologically (Figure 3C). Inhibition of endocytosis with dynasore, a small GTPase 
inhibitor targeting dynamin, for 20 minutes did not affect the puro-signal whereas the late 
endosomal acidification inhibitor, chloroquine (CHQ), significantly attenuated it. The 
reduction in the puro-signal following CHQ treatment or with Rab7a mutant expression in 
axons was not as severe as that following treatment with the protein synthesis inhibitor 
cycloheximide (CHX) (Figure 3C), indicating that axonal protein synthesis is not exclusively 
endosome-dependent. We also saw a clear enrichment of the puro-signal associated with 
GFP-Rab7a, but not GFP-Rab5a, endosomes (Figures 3D-F), which was abolished by CHX 
treatment (Figure 3F). This enriched puro-signal was also reduced by GFP-Rab7aQ67L or 
GFP-Rab7aT22N (Figure 3F) or application of CHQ (Figure 3F), confirming that both Rab7a 
activity and late endosome maturation are essential for late endosome-sited translation.  
 
Axonal protein synthesis is regulated by target of rapamycin complex 1 (TORC1) cap-
dependent translation initiation (Campbell and Holt, 2001). Application of TOR inhibitor 
PP242 significantly reduced late endosome-sited protein synthesis (Figure 3F). We found 
that TOR co-precipitated with endogenous Rab7 (Figure S4A) and GFP-Rab7a in brain 
lysates (Figure S4B) and colocalized with GFP-Rab7a in RGC axons (Figure S4C). We then 
measured phosphorylated ribosomal protein S6 (p-S6), a marker of TOR-mediated 
translation activity, in Rab7 mutant axons. Expression of GFP-Rab7aQ67L or GFP-Rab7aT22N 
mutants led to a decrease in p-S6 levels in axons compared to GFP-Rab7a and GFP (Figure 
S4D), without affecting the upstream TOR activation pathways (Figures S4E and S4F).  
 
Mitochondria reside at endosomal translation hotspots  
Mitochondrial respiration helps to sustain protein synthesis and, in axons, focal translation 
hotspots have been reported to correlate with nearby mitochondria (Spillane et al., 2013). We 
observed that Rab7a-endosomes are frequently in contact with mitochondria in axons 
(Figures S5A and S5B). Live imaging showed that they often pause when they encounter 
mitochondria and form apparent contacts that persist for over 2 minutes (Figures S5C and 
S5E). While close associations were also seen between Rab5a-endosomes and 
mitochondria, these associations were brief and rarely persisted over prolonged periods 
(Figures S5D-F). In agreement with observations in HeLa cells (Wong et al., 2018), we found 
that contacts between constitutively active Rab7a (GFP-Rab7aQ67L)-endosomes and 
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mitochondria in axons remained for a longer time than those between wild-type Rab7a-
endosomes and mitochondria (Figures S5D-F).  
 
To explore if late endosomes in association with mitochondria coincide with translational 
hotspots, we first investigated the spatial relationship between RNA granules, mitochondria 
and late endosomes (Figure 3G, Movie S4). Approximately 35% of GFP-Rab7a-endosomes 
were found adjacent to mitochondria, and 80% of these were associated with RNA granules 
(Figure 3H). We then asked whether newly synthesized proteins are found at these sites 
(Figures 3I and 3J). Indeed, 76% of Rab7a-endosomes in close proximity to mitochondria 
had an enriched puro-signal (Figure 3K), suggesting that late endosomes adjacent to 
mitochondria are sites of mRNA translation. We also noted that 44% of late endosomes with 
an enriched puro-signal were not associated with mitochondria, indicating that not all 
endosome-associated translation occurs in the presence of mitochondria.  
 
mRNAs encoding mitochondrial proteins are translated on Rab7a-endosomes 
The observed spatial coincidence of mitochondria, late endosomes and nascent proteins 
raises the possibility that endosomes are sites for the translation of mRNAs encoding 
proteins that regulate or maintain mitochondrial function. To test this idea, we first focused on 
the RNA-binding protein SFPQ (splicing factor proline and glutamine rich) that coordinates 
the axonal transport of mRNAs critical for mitochondria, and is enriched near mitochondria 
and ribosomes in axons (Cosker et al., 2016). In addition to the previously identified RBPs, 
we found that SFPQ co-precipitated with endogenous Rab7 (Figure 4A) and with GFP-
Rab7a (Figure 4B) in brain lysates. In axons, 47% of GFP-Rab7a endosomes colocalized 
with SFPQ (n=137 vesicles, N=80 axons) (Figure 4C). 
 
Time-lapse imaging showed an association between Cy5-labeled laminB2 mRNA (lmnb2), 
one of the SFPQ-regulated mRNAs important for mitochondrial integrity and axon survival 
(Cosker et al., 2016; Yoon et al., 2012), and GFP-Rab7a-endosomes in axons (Figure 4D). 
To investigate whether the Rab7a-endosome-associated lmnb2 mRNA is translationally 
active, we used live single-molecule nascent polypeptide imaging based on the SunTag 
fluorescent tagging system to visualize axonal Lamin B2 (LB2) protein synthesis in real time 
(Figure 4E) (Wang et al., 2016; Wu et al., 2016; Yan et al., 2016). As the nascent peptide is 
synthesized, super-folder GFP-tagged single-chain antibody fragments (scFv-sfGFP) rapidly 
bind to the 24 SunTag epitopes fused to the N-terminal of LB2, visible as a bright fluorescent 
spot. Cy5-labeled SunTag-lmnb2 mRNA was electroporated into eye primordia of embryos 
expressing RFP-Rab7a and scFv-sfGFP. We observed a striking colocalization between the 
three signals: RFP-Rab7a-endosomes, Cy5-SunTag-lmnb2 mRNA and sfGFP-labeled newly 
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synthesized SunTag-LB2 proteins in axons (Figure 4F, Movie S5). As expected, the 
proportion of actively translating mRNAs in axons or on late endosomes, indicated by the 
percentage of Cy5-SunTag-lmnb2 colocalizing with SunTag-LB2 spots, was decreased by 
exposing the axons to a high concentration of puromycin, which blocks protein synthesis and 
induces the release of nascent polypeptides (Figures 4G and 4H). Interestingly, the 
percentage of Rab7a-endosomes associated with SunTag-lmnb2 mRNA remained 
unchanged (Figure 4I). The same effect was observed following application of CHQ (Figures 
4G-I), suggesting that the mechanism by which late endosomes regulate protein synthesis 
involves mRNA translation, not mRNA binding.  
 
To see if endogenous lmnb2 mRNA could be observed on endosomes, we first used co-IP 
followed by qRT-PCR and found that endogenous lmnb2 mRNA was associated with Rab7a-
endosomes (Figure 4J). We then visualized the translation of native lmnb2 mRNA using 
puromycylation coupled with the proximity ligation assay (Puro-PLA) (tom Dieck et al., 2015) 
and found the LB2 Puro-PLA signal in close proximity to Rab7a-endosomes (Figure 4K). This 
was further confirmed by super-resolution microscopy which revealed LB2 Puro-PLA puncta 
decorating Rab7a-endosomes (Figure 4L). Application of CHQ, CHX and PP242 all 
significantly reduced the amount of LB2 Puro-PLA puncta in axons (Figure 4M), indicative of 
protein synthesis inhibition. To extend these findings to another mitochondria-related protein, 
we examined the axonally synthesized Voltage-dependent anion-selective channel protein 2 
(VDAC2) (Shigeoka et al., 2016), which is involved in exchanging solutes across the outer 
mitochondrial membrane (Naghdi and Hajnoczky, 2016). We found vdac2 mRNA also co-
precipitated with GFP-Rab7a (Figure 4N). We then confirmed that VDAC2 was locally 
synthesized by Puro-PLA, and that CHQ, CHX and PP242 reduced the signal in axons 
(Figure 4O). Taken together, these results show that late endosome-coupled translation can 
supply nascent proteins that have a role in maintaining axonal mitochondrial function.  
 
CMT2B-associated Rab7a mutations cause dominant effects on late endosomal 
trafficking and axonal integrity  
The autosomal-dominant neurological disorder CMT2B is associated with missense 
mutations of four amino acids in the human rab7a gene (Cogli et al., 2009). This rare 
neuropathy primarily affects the peripheral sensorimotor systems, leading to distal sensory 
loss, muscle weakness and atrophy. The mechanism behind how these mutations induce 
axonopathy remains elusive (BasuRay et al., 2010; Cherry et al., 2013; Cogli et al., 2010; 
Janssens et al., 2014; Liu and Wu, 2017; Spinosa et al., 2008). We wondered if our findings 
of late endosome-associated axonal translation, especially of mRNAs essential for 
mitochondrial and axonal integrity, could be relevant to understanding CMT2B. As the amino 
 9 
acid sequence of Xenopus Rab7a is 96% identical to human Rab7a, including the four 
residues identified as mutated in CMT2B patients (L129F, K157N, N161T/I and V162M), we 
generated four GFP-tagged pathological mutants Rab7aK157N, Rab7aL129F, Rab7aV162M, 
Rab7aN161T and expressed them in the Xenopus RGCs. In distal RGC axons expressing 
CMT2B-linked mutants, discrete GFP-positive puncta were clearly visible with each mutant, 
resembling patterns observed in wild-type GFP-Rab7a and CA GFP-Rab7aQ67L, in contrast to 
the more diffuse signal observed for the DN GFP-Rab7aT22N (Figure 5A). Live imaging 
revealed that expression of CMT2B mutants affects direction, frequency of pausing and 
average speed of LysoTracker-positive vesicles in RGC axons (Figures 5B-5F), suggesting 
conserved dominant effects of these mutants on late endosomal trafficking in our system 
(Ponomareva et al., 2016; Zhang et al., 2013).  
 
Severe defects in RGC axonal projections in vivo were also noted in DiI labeling experiments 
at stage 45, when most of these axons have established synaptic connections in the optic 
tectum of the midbrain. The majority of embryos expressing Rab7a disease mutants had 
fewer axons in the optic tract and the optic tectum (Figures 5G, 5H and 5I). To test whether 
this effect on axons was autonomous, we performed mRNA injections into only one of the 
two dorsal blastomeres at four-cell stage, leading to embryos in which expression was 
restricted to one half of the central nervous system (Figure 5J). As RGC axons in Xenopus 
cross at the optic chiasm, contralaterally projecting mutant axons navigate through wild-type 
tissue. Although less severe, RGCs axons expressing GFP-Rab7aV162M or GFP-Rab7aN161T in 
the wild-type brain also displayed less dense projections at stage 45 (Figures 5K and 5L). To 
distinguish whether the defects at stage 45 optic projections were the result of a failure to 
grow initially or to degeneration after growth, we examined the projections 3-4 days earlier, at 
stage 39. No obvious axon projection phenotypes were observed in mutant-expressing 
embryos at stage 39 (Figures 5M and 5N), suggesting that Rab7a-CMT2B mutants affect 
axonal maintenance after their initial growth.  
 
CMT2B-associated Rab7a mutations disrupt axonal translation of mRNAs essential for 
mitochondrial integrity  
The loss of axonal integrity induced by CMT2B mutants could be preceded by impaired intra-
axonal translation. Indeed, puromycin labeling revealed a decrease in nascent protein 
synthesis in growth cones of somaless RGC axons from stage 33/34 embryos expressing 
each of the four CMT2B mutants compared to GFP-Rab7a or GFP control (Figures 6A and 
6B). The translation marker p-S6 in growth cones was also reduced by all four of the 
CMT2B-related Rab7a mutants (Figure 6C). Finally, the percentage of CMT2B Rab7a-
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mutant endosomal puncta colocalizing with enriched puromycin signal was significantly 
decreased compared to wild-type GFP-Rab7a endosomes (Figure 6D). 
 
To test if the synthesis of proteins needed for mitochondrial function was affected in axons 
expressing CMT2B mutants, we first used the SunTag method and found that the proportion 
of actively translating SunTag-lmnb2 mRNAs was significantly reduced in RFP-Rab7aV162M- 
or RFP-Rab7aN161T-expressing axons (Figure 6E). Moreover, there was a significant 
reduction of newly synthesized SunTag-LB2 proteins on mutant-associated endosomes 
compared to wild-type RFP-Rab7a-endosomes (Figure 6F). Interestingly, the percentage of 
wild-type or mutant endosomes associated with Cy5-labeled mRNA remained constant 
(Figure 6G), suggesting that Rab7a disease mutations do not alter the association of lmnb2 
mRNAs with late endosomes but rather diminish their translation.      
 
Next, we asked whether the synthesis of native LB2 and VDAC2 proteins was affected by 
expressing CMT2B-related Rab7a mutants. Overexpression of GFP-Rab7a led to around 
20% decrease in nascent axonal LB2 as measured by LB2 Puro-PLA (Figures 6H and 6I), 
suggesting that LB2 local synthesis is sensitive to altered Rab7a levels in axons. Expression 
of each of the four CMT2B Rab7a-mutants, however, caused a significantly larger drop 
(approximately 35% decrease) in new LB2 synthesis (Figures 6H and 6I). Three out of four 
mutants, but not wild-type GFP-Rab7a, resulted in a reduction in VDAC2 Puro-PLA puncta 
(Figure 6J). Together, these results suggest that CMT2B Rab7a mutations compromises 
axonal translation of mRNAs, including those encoding proteins essential for mitochondrial 
integrity. 
 
CMT2B-associated Rab7a mutations disrupt mitochondrial integrity 
As CMT2B-associated Rab7a mutants down-regulate axonal translation of mitochondrial 
proteins, we wondered whether mutant-expressing axons exhibit abnormal mitochondrial 
phenotypes. To address this question, we first analyzed mitochondrial morphology in RGC 
axons expressing each of the four CMT2B Rab7a mutants. MitoTracker-labeled mitochondria 
in CMT2B Rab7a mutant-expressing axons exhibited highly elongated profiles (Figure 7A), 
compared to GFP-Rab7a or GFP controls (Figure 7B), while the density of mitochondria 
remained unchanged (Figure 7C), consistent with the mitochondrial phenotypes seen when 
axonal LB2 synthesis was inhibited (Yoon et al., 2012). Defective axonal mitochondrial 
trafficking is a sign of altered mitochondrial physiology (Roque et al., 2016; Sheng and Cai, 
2012), so we analyzed mitochondrial dynamics in axons expressing Rab7aV162M during 5-
minute time-lapse imaging intervals. We found a decrease of anterograde mitochondrial 
transport in CMT2B-mutant expressing axons (Figure 7D), and an increase in retrograde 
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transport (Figure 7D), compared to GFP-Rab7a or GFP control axons. Finally, we measured 
mitochondrial membrane potential (ΔΨm), which drives ATP production, by quantifying the 
accumulation of the cationic fluorescent probe tetramethylrhodamine methyl ester (TMRM) in 
mitochondria along axons and found a significant ΔΨm reduction in axons expressing 
Rab7aV162M compared to the GFP control or wild-type GFP-Rab7a (Figure 7E).  
 
Discussion 
 
Our results support a model in which Rab7a-endosomes are sites for mRNA translation in 
axons, generating focal hotspots of local protein synthesis often associated with 
mitochondria (Figure 7F). Moreover, we found that translation of nuclear-encoded 
mitochondrial mRNAs essential for mitochondrial function occurs at these hotspots.  
 
Axonal mRNA localization relies on specific association with RBPs and targeted transport 
through direct or indirect binding with cytoskeletal motor proteins (Buxbaum et al., 2015). Our 
live imaging analysis of RNA granules, mRNAs and RBPs collectively support this view as 
they provide evidence for directed transport of RNPs in RGC axons, mostly independent 
from endosomal trafficking. However, we also found that around a quarter of oscillatory and 
slow-moving RNPs are associated with endosomes in axons. How RNPs become tethered to 
the endosomes remains to be determined. A lipid-binding adaptor protein has been proposed 
as the mechanism for mRNA recruitment on endosome in fungal hyphae (Pohlmann et al., 
2015). This mechanism may be conserved since several different RBPs (SFPQ, Vg1RBP, 
FXR) were found to be part of the endosomal-associated complex in our system.  
 
It has been suggested that ribosomes assemble on endosome-associated mRNAs to 
activate translation (Higuchi et al., 2014), and we found ribosomal proteins associated with 
late endosomes in axons. In addition, the enrichment of newly synthesized proteins at 
Rab7a-endosomes, indicates that late endosomes are hotspots of local protein synthesis. 
Rab7a function is required for axonal translation, since both CA and DN Rab7a mutants 
caused down-regulation of translation. Previous work has shown that the endosomal sorting 
complex required for transport II (ESCRT-II) colocalizes with Rab7 in RGC axons. ESCRT-II 
knockdown causes a similar decrease (~20%) in axonal protein synthesis (Konopacki et al., 
2016), suggesting a potential role of ESCRT-II in this process. Not all intra-axonal translation 
requires endosomal function, as the protein synthesis inhibitor, cycloheximide, decreases 
axonal protein synthesis more severely (~50%). Our results also showed the presence of 
mRNAs and ribosomes on early Rab5a-endosomes, but neither expression of Rab5a 
mutants nor the endocytosis inhibitor, dynasore, revealed significant effects on constitutive 
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axonal protein synthesis. Future work will be needed to determine why late but not early 
endosomes seem to regulate axonal translation in this system.  
 
Translation hotspots have previously been reported in both axons and dendrites (Eberwine et 
al., 2001; Kim et al., 2013; Spillane et al., 2013; Wong et al., 2017). In axons, hotspots 
correlate with the presence of mitochondria (Spillane et al., 2013). In accordance with these 
observations, we found that hotspots of late-endosome associated translation were often in 
close proximity to mitochondria. Strikingly, live imaging revealed that Rab7a-endosomes 
remained in contact with mitochondria for prolonged periods. A direct association between 
late endosomes/lysosomes and mitochondria has been reported in HeLa cells and correlates 
with mitochondrial fission events (Wong et al., 2018). However, no mitochondrial fission 
event was observed in RGC axons when late endosomes docked on mitochondria, 
suggesting that other molecular activities may also be involved in these interactions. 
Mitochondria-linked mRNAs represent one of the main categories of translating mRNAs in 
adult axon terminals in mouse (Shigeoka et al., 2016) and their local translation is essential 
for the maintenance of mitochondrial function (Gale et al., 2017; Kaplan et al., 2009; Yoon et 
al., 2012). We found that late endosomes are sites of axonal translation of mRNAs that are 
essential for mitochondria. Indeed, the RBP SFPQ, that orchestrates a mitochondria-related 
RNA regulon (Cosker et al., 2016), and its cargo lmnb2 mRNA were found on late 
endosomes in axons. Moreover, we showed that Rab7a-endosomes are sites for the local 
synthesis of LB2, which is key to mitochondrial and axonal integrity (Cosker et al., 2016; 
Yoon et al., 2012). It is not yet clear whether the association with mitochondria can stimulate 
late endosomal-sited translation, and identification of a tethering complex may be essential to 
answer this question. In addition, the observed close association of the ER with RNA 
granules and late endosomes in RGC axons opens the possibility of its involvement in late 
endosomal trafficking and/or translation-associated activity. It is also of interest to note that 
while mitochondrial mRNAs represent only 5% of the total RGC axonal translatome 
(Shigeoka et al., 2016), global axonal protein synthesis decreases by 20% when Rab7a 
function or late endosome maturation is perturbed. This suggests that endosome-associated 
translation is involved in other local physiological processes in axons, and our finding that β-
actin mRNAs also associate with endosomes supports this idea. 
 
The inherited peripheral neuropathy CMT2B is caused by any one of five rab7a missense 
mutations (e.g. L129F, K157N, N161T/I, V162M) (Houlden et al., 2004; Meggouh et al., 
2006; Verhoeven et al., 2003; Wang et al., 2014). Despite Rab7a being a ubiquitous protein, 
axons of peripheral neurons are particularly susceptible to CMT2B-associated mutations. 
Different molecular mechanisms have been proposed to explain this. rab7a CMT2B-
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associated mutations show perturbed axonal transport of late endosomes (Ponomareva et 
al., 2016; Zhang et al., 2013), an effect we also observed in our system. These disrupted 
endosomal dynamics are correlated with altered signaling responses to neurotrophic factors 
in axons, in particular nerve growth factor (NGF) (BasuRay et al., 2010; Zhang et al., 2013). 
Another explanation is that rab7a mutations disrupt the regulation of effectors that function 
specifically in the peripheral nervous system such as the intermediate filament, peripherin, 
which has been shown to interact directly with Rab7a (Cogli et al., 2013). In this study, we 
propose an additional mechanism that may contribute to CMT2B disease, i.e. that Rab7a 
mutants affect local translation. Local translation is thought to be particularly important in the 
distal portions of long axons, such as sensory and motor neurons, as it supplies new proteins 
to meet local demand far from the soma. In this regard, it is of note that the axonal 
phenotypes observed in CMT2B-expressing peripheral sensory axons (Ponomareva et al., 
2016), and retinotectal axons in this study, are typical of the axonal phenotypes seen when 
subcellular RNA-based mechanisms are dysregulated (Yoon et al., 2012). We found 
compromised local protein synthesis in CMT2B mutant-expressing axons and, in particular, 
of known axonal survival factors, such as LB2 and VDAC2. The fact that CMT2B mutants did 
not affect the association of laminb2 mRNAs with late endosomes while they did reduce 
protein synthesis suggests that these Rab7a disease mutants affect the efficiency of 
endosome-sited translation. Further work will be required to understand the exact 
mechanistic role of Rab7a in this process, and how much the reduced local translation 
contributes to the axonal and mitochondrial phenotypes seen in CMT2B mutant expressing 
axons. In view of the emerging functional interactions between endosomes and 
mitochondria, it will also be of interest in the future to find out if other aspects of the cross-
talk between these two organelles are modulated by Rab7a functions in axons and whether 
these are perturbed in CMT2B disease.   
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Figure Legends 
 
Figure 1. RNA granules are associated with endosomes in axons. 
(A) Schematic of labeling endogenous RNAs in Xenopus central nervous system (CNS). (B) 
RGC axon shaft and growth cone containing Cy3-RNA granules undergoing oscillatory 
motions (B1), slow movement (B2) and ffast movement (B3). Asterisks show the origin of the 
tracks. The frame-to-frame speeds are indicated by color code. The tracks are presented first 
at same magnification and then higher magnification for B1 and B2. (C) Proportions of axonal 
Cy3-RNA granules displaying indicated motion types. (D) Speed distribution from average 
velocities of moving Cy3-RNA granules showing fast-moving and slow-moving populations in 
both anterograde (blue) and retrograde (red) directions (gaussian mixture model). N=1022 
moving RNA granules in 38 axons. (E) Scatter plot showing individual Cy3-RNA granule 
speed as a function of fluorescent pixel intensity (E1) Violin plot showing the speed 
distribution of Cy3-RNA granules with pixel intensity either more or less than 5 arbitrary units; 
For C, D, E: N=4995 RNA granules analyzed in 38 axons. (F) (F1) RGC axon segment 
showing the association between Cy3-RNA granules (red) and GFP-Rab5a (green) signals 
(white and yellow arrowheads indicate two different RNA granules). (F2) Kymographs (1 min) 
of the axon segment presented in F1. (G) (G1) RGC axon segment showing the close 
association between Cy3-RNA granules (red) and GFP-Rab7a (green) signals (white and 
yellow arrowheads indicate two different RNA granules). (G2) Kymographs (1 min) of the 
axon segment presented in G1. (H) Proportions of Cy3-RNA granules associated with GFP-
Rab5a or GFP-Rab7a displaying the indicated motions (N=52 and N=56 RNA granules 
analyzed in respectively GFP-Rab5a and GRP-Rab7a expressing axons). (I) Speed of Cy3-
RNA granules moving with or without GFP-Rab5a or GFP-Rab7a-endosomes in axon shafts 
(N=71 and N=52 RNA granules analyzed, respectively, for GFP-Rab5a and GRP-Rab7a 
expressing axons). (J, K) Average pixel intensity (normalized to the brightest pixel within 
each axon) (J) and area (normalized to the area of the largest granule) (K) of Cy3-RNA 
granules away from or in contact with GFP-Rab5a- or GFP-Rab7a-endosomes (N=192 and 
N=82 RNA granules analyzed, respectively, for GFP-Rab5a and GRP-Rab7a expressing 
axons). Mean±s.e.m.; **P<0.01, ***P<0.001, Wilcoxon Ranksum Test in E, Mann-Whitney 
test in I-K. Scale bars: 1μm in B; 5μm in F, G. Time stamps are in the format of sec:ms. See 
also Figures S1, S2 and Movie S1. 
 
Figure 2. Ribosomes, RNA-binding proteins and mRNAs localize to endosomes in 
axons.  
(A) Colocalization between endosomal markers and RBPs or ribosomal proteins. (B) 
Pearson’s coefficient between endosomal markers and RBPs or ribosomal proteins. N, 
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number of axon segments analyzed. (C) Time-lapse images and kymographs (1 min) 
illustrating RPS3A-GFP association with RFP-Rab5a- or Rab7a-endosomes (yellow 
arrowheads) in axons. (D) Motion types of RFP-tagged Rab5a- (N=27 axons), Rab7a- (N=29 
axons) or LAMP-1- (N=22 axons) endosomes associated with RPS3A-GFP signal. (E) Time-
lapse images and kymographs illustrating GFP-Vg1RBP association with RFP-Rab5a- or 
Rab7a-endosomes (yellow arrowheads) in axons. (F-G) Frequency (F) and motion types (G) 
of GFP-Vg1RBP associated with RFP-tagged Rab5a- (N=15 axons), Rab7a- (N=13 axons) 
or LAMP-1- (N=12 axons) endosomes. (H-I) Frequency (H) and motion types (I) of β-actin 
molecular beacon (MB) signals associated with GFP-Rab5a- (N=22 axons) or GFP-Rab7a- 
(N=20 axons) endosomes. (J) Representative images showing β-actin MBs associated with 
GFP-Rab5a- or GFP-Rab7a-endosomes (white arrowheads) in axons. Mean±s.e.m. Scale 
bars: 2.5μm in A; 2μm in C, E; 5μm in J. Time stamps are in the format of sec:ms. See also 
Figure S3 and Movies S2, S3. 
 
Figure 3. Perturbed Rab7a activity and late endosome maturation reduced intra-axonal 
protein synthesis. 
(A) Heat maps indicating relative puromycin fluorescent intensity in somaless RGC growth 
cones. (B) Quantitative immunofluorescence (QIF) analysis of puromycin incorporation in 
somaless growth cones expressing the indicated constructs. (C) QIF analysis of puromycin 
incorporation in somaless growth cones upon acute pharmacological treatments. (D) 
Nascent proteins labeled by puromycin colocalizing with GFP-Rab7a-endosomes but not 
GFP-Rab5a-endosomes. (E) Plotted fluorescent signals across the dotted line in D. (F) 
Percentage of GFP-tagged Rab5a-, Rab7a- and Rab7a mutant-endosomes colocalizing with 
puromycin enrichment in axons. (G) Close association of GFP-Rab7a-endosomes (green), 
Cy3-RNA granules (red) and mitochondria (blue) in RGC axons. White arrows indicate Cy3-
RNA granules associated with GFP-Rab7a-endosomes. (G1, G2) Examples of time-lapse 
sequences showing Cy3-RNA granules associated with GFP-Rab7a-endosomes next to 
mitochondria. (H) Percentage of GFP-Rab7a-endosomes in contact with mitochondria, 80% 
of which are associated with Cy3-RNA granules. (N=335 GFP-Rab7a endosomes, N=32 
axons). (I) RGC axon segments expressing Mito-GFP (green) and RFP-Rab7a (red) in which 
newly synthesized proteins are visualized using puromycin labeling (blue). Puromycin signal 
is enriched on RFP-Rab7a-associated endosomes in proximity to mitochondria (pink 
arrowheads) and distant from mitochondria (yellow arrowhead). (J) Plotted fluorescent 
signals along the axon segment presented in I (A.U: Arbitrary Units). (K) Percentage of RFP-
Rab7a-endosomes in contact with mitochondria with or without puromycin enrichment in 
axons (N=52 axons). Mean±s.e.m.; N, number of growth cones analyzed in B, C; or number 
of endosomes analyzed in F. n.s., not significant, *P<0.05, ***P<0.001, Mann-Whitney test. 
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Scale bars: 5μm in A; 2μm in D, G, I. Time stamps are in the format of sec:ms. See also 
Figures S4, S5. 
 
Figure 4. mRNAs essential for mitochondria integrity are translated on Rab7a-
endosomes in axons. 
(A) Co-immunoprecipitation (IP) between Rab7 and Vg1RBP, FXR, SFPQ, RPS3A and 
RPL10A in brain lysates. (B) Co-IP between GFP-Rab7a and SFPQ in brain lysates. (C) 
Colocalization of GFP-Rab7a with SFPQ in axons (white arrowheads). (D) RGC axon 
segment analyzed by live imaging and its corresponding kymograph (1 min) showing the 
association between Cy5-labeled laminb2 mRNA (lmnb2) and GFP-Rab7a-endosomes. (E) 
Schematic of SunTag system-based nascent polypeptide labeling to visualize Lamin B2 
(LB2) synthesis. (F) Representative images showing the nascent SunTag-LB2 protein 
(green), the SunTag-lmnb2 mRNA (blue) and the RFP-Rab7a-endosome (red) in live axons 
(indicated by white arrows). (G) Percentage of SunTag-lmnb2 mRNA associated with 
nascent SunTag-LB2 protein (translating) per 50µm axon segment. (H) Percentage of 
SunTag-lmnb2 mRNA associated with RFP-Rab7a-endosomes colocalized with nascent 
SunTag-LB2 protein (translating). (I) Percentage of RFP-Rab7a-endosomes associated with 
SunTag-lmnb2 mRNA. (J) Quantitative analysis of lmnb2 mRNA by qRT-PCR of cDNA 
synthesized from RNAs co-precipitated with GFP and GFP-Rab7a from brain extracts (N=3 
biological replicates). (K) Example of LB2 puro-PLA signals in proximity to GFP-Rab7a 
endosomes (white arrow heads) in axons. (L) Super-resolution microscopy analysis of LB2 
puro-PLA signals next to a GFP-Rab7a-endosome. (M) Quantification of LB2 Puro-PLA 
signals in treated RGC axons. (N) Quantitative analysis of vdac2 mRNA by qRT-PCR of 
cDNA synthesized from RNAs co-precipitated with GFP and GFP-Rab7a from brain extracts 
(N=3 biological replicates). (O) Quantification of VDAC2 Puro-PLA signals in treated RGC 
axons. N, number of axon segments analyzed in G, H, I, M, O. Mean±s.e.m.; n.s., not 
significant, *P<0.05, **P<0.01, ***P<0.001, Mann-Whitney test. Scale bars: 5μm in C, D, K; 
1μm in F; 500nm in L. Time stamps are in the format of sec:ms. See also Movies S4. 
 
Figure 5. Expression of Rab7a CMT2B mutants perturbs late endosome trafficking and 
axonal projection in vivo.  
(A) Representative images of wild-type or mutant GFP-Rab7a-endosomes in cultured axons. 
(B) Number of LysoTracker-positive vesicles per 50µm of axon (N, number of axon segments 
analyzed). (C) Area of individual LysoTracker vesicles in axons (N=vesicles, GFP=180, 
WT=187, K=137, L=97, V=140, N=89). (D) Percentage of LysoTracker vesicles moving 
anterogradely or retrogradely over 1-minute movie (N=vesicles, GFP=130, WT=114, K=249, 
L=78, V=155, N=96). (E, F) Frequency of pausing (E) and average speed (F) of individual 
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vesicles over 1-minute movie (N=number of vesicles, GFP=130, WT=114, K=249, L=78, 
V=155, N=96). (G) Schematic of labeling of stage 45 RGC axons in vivo in bilaterally injected 
embryos. OT: optic tract. (H) Representative images of RGC axon projections in stage 45 
embryos expressing GFP, wild-type Rab7a or CMT2B disease mutants. (I) Percentage of 
embryos with defective RGC projections with less than 30 axons. (J) Schematic of RGC 
axons labeling in unilaterally injected embryos. (K) Representative images of RGC axon 
projections in stage 45 embryos expressing GFP, wild-type Rab7a or GFP-Rab7aV162M. (L) 
Axon projection volume post-optic chiasm in stage 45 embryos expressing GFP (N=31 
embryos), wild-type Rab7a (N=32 embryos), GFP-Rab7aV162M (N=37 embryos) or GFP-
Rab7aN161T (N=33 embryos). (M) Representative images of RGC axon projections in stage 
39 embryos expressing GFP, wild-type Rab7a or GFP-Rab7aV162M. (N) Axon projection 
volume post-optic chiasm in stage 39 embryos expressing GFP (N=25 embryos), wild-type 
Rab7a (N=33 embryos), GFP-Rab7aV162M (N=24 embryos) or GFP-Rab7aN161T (N=28 
embryos). Mean±s.e.m.; n.s., not significant, *P<0.05, **P<0.01, ***P<0.001, Fisher’s exact 
test in D or Mann-Whitney test in E, F, I, L and N. Scale bars: 10μm in A, 100μm in H, K and 
M. 
 
Figure 6. CMT2B-associated Rab7a mutations disrupt axonal translation of mRNAs 
essential for mitochondrial integrity. 
(A) Heat maps indicating relative puromycin fluorescence in RGC growth cones. (B) 
Quantitative immunofluorescence (QIF) analysis of puromycin incorporation in somaless 
RGC growth cones expressing the indicated constructs. (C) QIF analysis of phospho-S6 
ribosomal proteins in growth cones expressing the indicated constructs. (D) Percentage of 
GFP-Rab7a CMT2B mutant-endosomes with puromycin enrichment in axon shafts are 
decreased compared to wild-type GFP-Rab7a-endosomes. (E) Percentage of SunTag-lmnb2 
mRNA associated with nascent SunTag-LB2 protein (translating) per 50µm axon segment. 
(F) Percentage of SunTag-lmnb2 mRNA associated with RFP-Rab7a- or Rab7a CMT2B 
mutant-endosomes colocalized with nascent SunTag-LB2 protein (translating). (G) 
Percentage of RFP-tagged Rab7a- or Rab7a CMT2B mutant-endosomes colocalized with 
Cy5-labeled SunTag-lmnb2 mRNA. (H) Representative LB2 puro-PLA signals in axons 
expressing GFP, GFP-Rab7a and GFP-Rab7a CMT2B mutants. (I) Quantification of LB2 
Puro-PLA signals in axons expressing GFP, GFP-Rab7a and GFP-Rab7a CMT2B mutants. 
(J) Quantification of VDAC2 Puro-PLA signals in axons expressing GFP, GFP-Rab7a and 
GFP-Rab7a CMT2B mutants. Mean±s.e.m.; N, number of growth cones analyzed in B, C; 
number of endosomes analyzed in D; or number of axon segments analyzed in E, F, G, I, J. 
n.s., not significant, *P<0.05, ***P<0.001, Mann-Whitney test. Scale bars: 5μm in A, H. See 
also Movies S5. 
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Figure 7. Expression of CMT2B-associated Rab7a mutations compromise 
mitochondrial integrity. 
(A) MitoTracker-labeled mitochondria illustrating variation in mitochondrial morphology in 
axons expressing GFP-Rab7a CMT2B mutants. (B) Quantification of mitochondrial length 
(N=number of mitochondria, GFP=301, WT= 148, K= 273, L= 268, V=225, N=279). (C) 
Quantification of number of mitochondria within 25μm axon segments. (D) Percentage of 
mitochondria transported anterogradely decreases in axons expressing GFP-Rab7aV162M 
CMT2B mutant, while the percentage of mitochondria transported retrogradely increases 
compared to the GFP control or GFP-Rab7a-expressing axons. (E) Quantification of 
mitochondrial membrane potential measured by TMRM fluorescent intensity showing a 
decrease in axons expressing GFP-Rab7aV162M CMT2B mutant (N=31 axons) compared to 
GFP control (N=44 axons) and GFP-Rab7a-expressing axons (N=31 axons). N, number of 
mitochondria analyzed. (F) Proposed model: mRNAs and translation machinery associate 
with late endosomes in axons. Late endosomes in proximity to mitochondria are sites for 
synthesis of proteins essential for mitochondria integrity. Late endosomal-sited translation is 
defective in axons expressing CMT2B-associated Rab7a mutants, causing a reduction of 
mitochondria-related mRNAs translation. N, number of axon segments analyzed in C, N, 
number of mitochondria analyzed in E. Mean±s.e.m.; n.s., not significant, ***P<0.001, Mann-
Whitney test. Scale bars: 5μm in A. 
 
Supplementary Figure Legends 
 
Figure S1. Spatial relationship between early endosomes, late endosomes, ER and 
Cy3-RNA granules in cultured RGC axons. Related to Figure 1 
(A) GFP-Rab5a-endosomes do not colocalize with Lyso-Tracker-labeled vesicles in distal 
axons (left). GFP-Rab7a-endosomes colocalize with Lyso-Tracker-labeled vesicles (right, 
white arrows). (B) GFP-Rab5a-endosomes do not colocalize with LAMP-1-associated 
vesicles in distal axons (left). GFP-Rab7a-endosomes colocalize with LAMP-1-associated 
vesicles (right, white arrows). (C) GFP-Rab5a- and GFP-Rab7a-endosomes are in close 
contact with ER-Tracker-labeled axonal ER, but they are structurally distinct. (D) Percentage 
of GFP-Rab5a- or GFP-Rab7a-endosomes co-labeled with Lyso-Tracker, LAMP-1 or ER-
Tracker. (E) Cy3-RNA granules are closely associated with ER-Tracker-labeled axonal ER 
(left). Kymograph of the axon segment indicated by the dotted outline (middle) shows little 
co-movement of the two signals (right). N, number of axon segments analyzed. Mean±s.e.m. 
Scale bars: 5μm in A, B, C, D, E1; 2μm in E2.      
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Figure S2. RNA granule motions in axons expressing wild-type or mutant GFP-Rab5a 
or GFP-Rab7a. Related to Figure 1 
(A) Average speed of Cy3-RNA granules in axons expressing GFP, GFP-tagged wild-type 
Rab5a (Rab5a) or Rab5a mutants (Rab5aQ80L, Rab5aS35N). Number of granules analyzed: 
GFP=547, Rab5a=1064, Rab5aQ80L=695, Rab5aS35N=524. (B) Average speed of Cy3-RNA 
granules in axons expressing GFP, GFP-tagged wild-type Rab7a (Rab7a) or Rab7a mutants 
(Rab7aQ67L, Rab7aT22N). Number of granules analyzed: GFP control=475, Rab7a=788, 
Rab7aQ67L=657, and Rab7aT22N=811. (A and B) For each of the three biological replicates we 
calculated a frequency distribution of speeds for the following bins: -2.5 to -2, -2 to -1.5, -1.5 
to -1, -1 to -0.5,-0.5 to 0, 0 to 0.5, 0.5 to 1, 1 to 1.5, 1.5 to 2, 2 to 2.5, and 2.5 to 3. For each 
bin the bar plot represents the mean of the 3 replicates. (C) Proportions of Cy3-RNA 
granules transported anterogradely or retrogradely in axons expressing GFP as control, 
GFP-tagged wild-type Rab5a or Rab5a mutants Rab5aQ80L, Rab5aS35N. Data from all repeats 
are pooled. Number of axons in GFP control=21, Rab5a=18, Rab5aQ80L =16, Rab5aS35N =17. 
(D) Proportions of Cy3-RNA granules transported anterogradely or retrogradely in axons 
expressing GFP as control (CT), GFP-tagged wild-type Rab7a (WT) or Rab7a mutants 
Rab7aQ67L, Rab7aT22N. Data from all repeats are pooled. Number of axons in GFP control 
=17, Rab7a =18, Rab7aQ67L =20, Rab7aT22N =20. Mean±s.e.m. 
 
Figure S3. Ribosomes associate with GFP-Rab5a- and GFP-Rab7a-endosomes in 
axons. Related to Figure 2 
(A) Representative Western Blot of Vg1RBP and ribosomal proteins RPL10A and RPS3A co-
immunoprecipitated with GFP-Rab5a and GFP-Rab7a in brain lysates. (B) qRT-PCR of 
cDNA synthesized from RNAs co-precipitated with GFP, GFP-Rab5a and GFP-Rab7a 
revealing a significant enrichment of β-actin mRNA in GFP-Rab5a- and GFP-Rab7a-
expressing brain extracts (N=3 biological replicates). (C) OMX Super-resolution microscopy 
revealing the presence of RPL10A and RPS3A puncta on GFP-Rab5a- or GFP-Rab7a-
containing endosomes in axons (left panels, white arrows). Orthogonal views of the indicated 
areas confirming the contact (yellow arrows) between the ribosomal proteins and endosomes 
(right panels). (D) Time-lapse images and kymographs illustrating RPS4X-GFP association 
with RFP-Rab5a- or Rab7a-endosomes (white arrowheads) in axons. Mean±s.e.m.; 
**P<0.01, Mann-Whitney test. Scale bars: 1μm in left panels in C and D; 200nm in right 
panels in C. 
 
Figure S4. Perturbing Rab7a function disrupts signaling downstream of TOR complex 
1 in RGC axons. Related to Figure 3  
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(A) Co-immunoprecipitation between endogenous Rab7 and TOR in brain lysates. (B) Co-
immunoprecipitation between GFP-Rab7a and TOR in brain lysates. (C) Representative 
immunocytochemistry images showing TOR signals in RGC axons expressing GFP-Rab5a 
or GFP-Rab7a. Pearson’s coefficient between endosomal markers and TOR. N, number of 
axons segments analyzed. (D) Representative phase contrast images and heat maps 
indicating relative phospho-S6 levels in growth cones expressing Rab7a mutants. GFP-
Rab7aQ67L or GFP-Rab7aT22N expression decreases the amount of phospho-S6 ribosomal 
proteins in growth cones compared to GFP or GFP-Rab7a-expressing growth cones. (E) 
Representative phase contrast images and heat maps indicating relative phospho-AKT levels 
in growth cones expressing Rab7a mutants. GFP-Rab7a, GFP-Rab7aQ67L or GFP-Rab7aT22N 
expression does not affect the amount of phospho-AKT in growth cones compared to the 
GFP control.  (F) Representative phase contrast images and heat maps indicating relative 
phospho-TOR levels in growth cones expressing Rab7a mutants. GFP-Rab7a, GFP-
Rab7aQ67L or GFP-Rab7aT22N expression does not affect the amount of phospho-TOR in 
growth cones compared to the GFP control. N, number of axon segments analyzed in C, or 
number of growth cones analyzed in D, E, F. Mean±s.e.m.; n.s., not significant, **P<0.01, 
***P<0.001, Mann-Whitney test. Scale bars: 5μm. 
 
Figure S5. Endosomes and mitochondria form contacts in RGC axons. Related to 
Figure 3  
(A) Representative super-resolution microscopy images showing the close proximity between 
RFP-Rab7a-endosomes and mitochondria (Mito-GFP) in RGC axons. Images in z-stacks 
showing the close proximity between the two signals in the Z-plane. Arrowheads indicate the 
close proximity between the two signals. (B) Distribution of distances between real or 
randomly distributed RFP-Rab7a endosomes and mitochondria (Mito-GFP). The distance of 
each endosome with its nearest mitochondria is shown as a fraction of the total number of 
endosomes. The arrow indicates that the largest number of endosomes lie between 0-200 
nm of the closest mitochondria (n=21 axons, n=188 endosomes). (C) Examples of time-lapse 
sequences showing the contact between GFP-Rab7a-endosomes and mitochondria 
(MitoTracker) in RGC axons. (D) Percentage of GFP-Rab5a- or GFP-Rab7a-endosomes 
contacting mitochondria for more than 10 seconds over 2-minute recording (N: number of 
axon segments analyzed). (E, F) Duration of endosome-mitochondria contacts over 2-minute 
recording (N=number of contacts analyzed, N=77 for GFP-Rab7a-endosomes, N=60 for 
GFP-Rab5a-endosomes, N=63 for GFP-Rab7aQ67L-endosomes). Mean±s.e.m.; n.s., not 
significant, ***P<0.001, Mann-Whitney test. Scale bars: 1μm (left panel) or 200nm (z-stacks) 
in A; 2.5μm in C. Time stamps are in the format of min:sec. 
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STAR Methods Text 
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Christine E. Holt (ceh33@cam.ac.uk). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Xenopus laevis Embryos  
Xenopus laevis eggs were fertilized in vitro and embryos were raised in 0.1x Modified Barth’s 
Saline (MBS; 8.8mM NaCl, 0.1 mM KCl, 0.24mM NaHCO3, 0.1 mM HEPES, 82µM MgSO4, 
33µM Ca(NO3)2, 41µM CaCl2) at 14-20°C and staged according to the tables of Nieuwkoop 
and Faber (Nieuwkoop and Faber, 1994). All animal experiments were approved by the 
University of Cambridge Ethical Review Committee in compliance with the University of 
Cambridge Animal Welfare Policy. This research has been regulated under the Animals 
(Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by 
the University of Cambridge Animal Welfare and Ethical Review Body (AWERB). 
 
Primary Xenopus Retinal Cultures 
Eye primordia were dissected from Tricaine Methanesulfonate (MS222) (Sigma-Aldrich) 
anesthetized embryos of either sex at stage 35/36 and cultured on 10µg/ml poly-L-lysine 
(Sigma-Aldrich)- and 10µg/ml laminin (Sigma-Aldrich)-coated glass bottom dishes (MatTek) 
in 60% L-15 medium (ThermoFisher), 1x Antibiotic-Antimycotic (ThermoFisher) at 20°C for 
24-48 hours. 10-20 eye primordia (from 5-10 embryos) were cultured per dish and, typically, 
2-3 dishes were used per experimental condition for each biological replicate. 
 
METHOD DETAILS 
Constructs  
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Xenopus GFP- or RFP-tagged Rab constructs GFP-Rab5a, RFP-Rab5a, GFP-Rab7a, RFP-
Rab7a, constitutively active mutant GFP-Rab7aQ67L, dominant negative mutant GFP-
Rab7aT22N in pCS2+ vector were previously reported (Falk et al., 2014). Point mutations of 
GFP-Rab5a to obtain the constitutively active mutant GFP-Rab5aQ80L and dominant negative 
mutant GFP-Rab5aS35N, and GFP-Rab7a or RFP-Rab7a to obtain the four CMT2B-
associated mutants Rab7aK157N, Rab7aL129F, Rab7aV162M and Rab7aN161T were performed by 
site-directed mutagenesis using QuikChange II Site-Directed Mutagenesis Kit (Agilent 
Technologies). Human and Xenopus Rab5a or Rab7a protein sequences were aligned to 
identify the amino acids to be mutated. Lamp1-RFP (Addgene) was cloned into pCS2+ 
vector. Xenopus Rps3a and Rps4x sequences were obtained by PCR from the Xenopus 
laevis cDNA library synthesized using SuperScript III First-Strand Synthesis System 
(ThermoFisher Scientific), and subsequently cloned into the N-terminal of GFP in pCS2+ 
vectors to construct the Rps3a-GFP and Rps4x-GFP plasmids. Xenopus Vg1RBP was 
obtained from pET21d-Vg1RBP-GFP by PCR and cloned into a GFP-containing pCS2+ 
vector, which has been previously described (Leung et al., 2006). Mitochondria-targeted GFP 
(Mito-GFP) was a gift from Michael Coleman (Department of Clinical Neuroscience, 
University of Cambridge, UK). Xenopus laevis laminb2 (lmnb2) cDNA sequence including the 
5’ and 3’ untranslated regions (UTRs) was obtained from IMAGE clone (Source Bioscience 
SB5157193) by PCR and cloned into pCS2+ vector for Cy5-labeled mRNA synthesis. 24 
SunTag tandem repeats were obtained from pcDNA4TO-24xGCN4_v4-kif18b-24xPP7 
(Addgene) by PCR and cloned into pCS2+ vector. lmnb2 5’UTR was cloned into 5’ end of the 
SunTag repeats, while lmnb2 coding sequence (CDS) and 3’UTR were cloned into 3’ end of 
the SunTag repeats, generating the lmnb2 5’UTR-24xSunTag-lmnb2 CDS-lmnb2 3’UTR 
construct, which can be used to generate Cy5-labeled SunTag-lmnb2 mRNA. scFv-sfGFP 
sequence obtained from pHR-scFv-GCN4-sfGFP-GB1-dWPRE (Addgene) by PCR was 
cloned into pCS2+ vector. The E.coli DH5α strain was used for all plasmid amplification 
steps. Capped RNA was in vitro transcribed using mMessage mMachine SP6 Transcription 
Kit (ThermoFisher Scientific). In case of Cy5-labeled mRNA synthesis, 1µl Cy5-UTP 
(PerkinElmer) was added to the reaction mixture during in vitro transcription.  
 
Blastomere Microinjection 
DNA and RNA were microinjected into both of the dorsal blastomeres at four- or eight-cell 
stage as previously described (Leung and Holt, 2008). Embryos were de-jellied with 2% 
cysteine (Sigma-Aldrich) in 1X MBS (pH 8), washed 3 times in 0.1X MBS and aligned on a 
grid in 4% Ficoll (Sigma-Aldrich) in 0.1X MBS, 1% penicillin (100 U/ml), streptomycin (100 
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µg/ml) and fungizone 0.25 µg/ml (Antibiotic-Antimycotic, Gibco). Injections of 5 nl of volume 
were performed using glass capillary needles (outer diameter: 1.0 mm; inner diameter: 0.5 
mm, Harvard Apparatus) and a microinjector (Picospritzer, General Valve). Cy3-UTP 
(PerkinElmer) was injected at 100µM. RNA of GFP- or RFP-tagged wild-type and mutant 
Rab5a were injected at a concentration of 100ng/µl. RNA of GFP and GFP- or RFP-tagged 
wild-type and mutant Rab7a were injected at a concentration of 200ng/µl. Mito-GFP and 
GFP-Vg1RBP DNA plasmids were injected at a concentration of 25ng/µl. Lamp1-RFP DNA 
plasmid was injected at a concentration of 50ng/µl.  
 
Targeted Eye Electroporation 
DNA plasmids [1µg/µl] or in vitro transcribed mRNAs [1µg/µl] were introduced into Xenopus 
eye primordia of stage 26-30 embryos by electroporation (Falk et al., 2007). Anaesthetized 
embryos were transferred to a “†” shaped chamber with the head positioned at the cross 
intersection and platinum electrodes positioned on either side, in the transverse channel. A 
borosilicate glass capillary needle (outer diameter: 1mm; inner diameter: 0.78mm, Harvard 
Apparatus) containing the DNA or RNA solution was inserted into the eye and a volume of 
40nl was injected. The capillary was withdrawn from the eye post-injection, immediately prior 
to delivering eight square wave electric pulses of 18V, with 50ms duration and 1000ms 
intervals. After electroporation, embryos were transferred to 0.1x MBS for recovery and 
electroporated eyes were cultured at stage 35/36. For live-imaging experiments, Rps3a-GFP 
or Rps4x-GFP DNA plasmids were electroporated into RFP-Rab5a or RFP-Rab7a RNA- or 
Lamp1-RFP DNA-injected embryos. In vitro transcribed Cy5-labeled laminb2 mRNA was 
electroporated into GFP-Rab5a or GFP-Rab7 RNA-injected embryos.  
 
Live Imaging in Xenopus Retinal Ganglion Cell Axons 
Cultured axons were imaged under a Perkin Elmer Spinning Disk UltraVIEW ERS, Olympus 
IX81 inverted microscope with a 60x 1.4NA silicone oil objective for 2 to 5 minutes with 
exposure times set between 300-500ms. Volocity (Perkin Elmer) was used for manual 
tracking of Rab7a or Rab5a-endosomes associated with either Cy3-RNA or GFP-Vg1RBP 
labeled granules. Associated signals were defined by their association/co-movement for >4s. 
A granule was defined as static/oscillatory if no directional transport further than 2µm within 
60 seconds was observed. To visualize ER, retinal cultures were incubated with 1µM ER-
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Tracker Red (ThermoFisher Scientific) for 15 minutes and washed 7 times with culture 
medium. To visualize acidic endosomes, retinal cultures were incubated with 50nM Lyso-
Tracker Red (ThermoFisher Scientific) for 30 minutes and washed 7 times with culture 
medium. Movies of Rab7a-endosomes and mitochondria were taken for 5 minutes directly 
after the cultures were incubated for 20 minutes in 50nM MitoTracker red CMXRos 
(ThermoFisher Scientific) dissolved in DMSO and washed 7 times with culture medium. To 
quantify mitochondria membrane potential, retinal cultures were incubated with 20nM 
tetramethylrhodamine methyl ester (TMRM) (ThermoFisher Scientific) for 20 minutes, 
followed by 4 washes and immediate image acquisition of single frames with constant laser 
power and exposure time. Object detection analysis on Volocity was then used to quantify 
the mean intensity of the TMRM signal in each mitochondrion present in 50µm of isolated 
axon shafts expressing the indicated constructs, excluding the last 20µm distal portion of the 
axon. The mitochondria outlines were then placed in an adjacent area clear of mitochondria 
to record the background fluorescent intensity. This reading was subtracted yielding the 
background-corrected intensity.   
 
Cy3-RNA Granules and LysoTracker Vesicles Analysis 
Particle movements were extracted from raw data movies with the plusTipTracker package 
(Applegate et al., 2011). We used the Watershed-based option in the Detection Settings for 
all movies. To detect individual features (granules), movies were denoised with 2 gaussian 
Kernels of size 1 pixel and 3 pixels respectively, corresponding to the sigma 1 & 2 in the 
Detection Settings of the plusTipTracker package. The K-Value (local threshold) was set to 
values between 2-5 depending on the background noise in the movies. The Tracking settings 
were held constant for all movies: Search Radius Range = 3-10, Minimum Sub-Track length 
= 4 frames (to discard background fluctuations), Maximum Gap Length = 3 (frames for which 
a particle is not detected due to overlap with another particle), Max Shrinkage Factor = 0, 
Maximum angle Forward/Backward= 30/0, Fluctuation Radius = 1.5. After running this 
analysis, several tracks (x-y coordinates) were generated for each movie. 
The tracks representing Cy3-RNA granule or LysoTracker vesicle movements in each movie 
were then post processed in a self-written MATLAB script to determine their motion types. 
First, a segmented line was drawn along the axon towards the anterograde direction. Then 
each (average) track direction was calculated. If the average direction points within 162 
degrees of the forward/anterograde direction of the drawn axon, the track is classified as 
anterograde and vice versa for retrograde. Furthermore, tracks that displace less than 2µm 
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from their origin were classified as oscillatory. To calculate the Cy3-RNA track/granule intensity 
a background region was drawn by hand and the average pixel intensity in this region 
subtracted from the average intensity of the granule for each track (Individual granule 
intensities are calculated in the detection part of the plusTipTracker script). The average track 
velocity was calculated as the average of all frame-to-frame velocities. 
 
Pixel Intensity, Area of Coverage and Particle Distance Analysis 
Images of fluorescently labeled RNA granules, Rab5a endosomes, Rab7a endosomes, or 
mitochondria were analyzed using custom-written scripts within the MATLAB environment. 
All grayscale fluorescent images were binarized using Otsu’s thresholding method (Otsu, 
1979). The binary images were segmented using a modified watershed method to obtain 
masks of labeled granules from each fluorescent channel. The resulting images were then 
visually inspected and the threshold was adjusted where granules were misidentified.  
The masks from the Cy3-RNA channel were compared spatially to each of the other three 
and the granules that overlapped with GFP-Rab5a, GFP-Rab7a or mitochondria, by at least 
one pixel, were identified. The Cy3-RNA granules were thus grouped as in contact or not in 
contact with the other component. The area of each granule was defined as the total number 
of pixels of its mask and was normalized to the smallest and largest granule areas within one 
image (typically of a single axon). Since the mask areas of brighter granules tended to be 
larger, we calculated the mean intensities of the brightest pixels within each mask to remove 
any possible dampening of the signal due to mask size. The number of brightest pixels to be 
included was separately determined for each of Cy3-RNA granule pairs and set as half of the 
average area of Cy3-RNA granule masks in that pair. Pixel intensities of the granules were 
obtained from the original grayscale image and normalized such that the minimum value 
would equal the binarization threshold and the maximum value was that of the brightest pixel 
within the corresponding image’s masks. 
The masks from RFP-Rab7a were compared to those from mitochondria to find the distances 
between objects in each image. Where an overlap between two objects from each channel 
existed, the distance between those objects was set to zero. Otherwise, the shortest distance 
between an object and its nearest neighbor in the other channel was calculated. These 
shortest distances for all objects were collated and analyzed. To create a randomized 
distribution of endosomes and mitochondria for comparison, the mean and standard 
deviations of their mask radii, number of particles, and axon dimensions were calculated. 
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Normal distributions based on these mean and standard deviations were created for each of 
the above variables. Random numbers of each particle type were drawn from normal 
distribution of particle numbers. Each particle was a circle of random radius drawn from the 
respective normal distribution. Particles were placed in axons whose width and length were 
drawn from corresponding distributions, as well. The distance between these randomly 
selected particles were measured and analyzed as described above. 
 
Immunoprecipitation 
For GFP immunoprecipitations, GFP, GFP-Rab5a or GFP-Rab7a expressing Xenopus brains 
were dissected from stage 35/36 embryos (70 embryos/condition) and homogenized in lysis 
buffer (20mM Tris, 100mM NaCl, 10mM MgCl2, 0.25% NP40, 10% Glycerol, 100μg/ml 
cycloheximide (Sigma-Aldrich)) supplemented with EDTA-free protease inhibitor cocktail 
(Roche), phosphatase inhibitor (Pierce) and 100U/ml SUPERase In RNase inhibitor 
(Ambion) for 5 minutes on ice. Following centrifugation for 5 minutes at 1000 x g, the 
supernatant was collected. For immunoprecipitation, the protein extracts were incubated for 
30 minutes at 4°C with beads coupled to an anti-GFP antibody (ab1218, Abcam). Beads 
were washed four times with lysis buffer and samples were either eluted from the beads by 
adding RLT buffer (Qiagen) and vortexing for 2 minutes for subsequent RNA isolation or 
eluted with 1x SDS sample buffer for 5 minutes at 95°C for protein and subsequent Western 
blot analysis as described below. For endogenous immunoprecipitations, brains from stage 
35/36 embryos (70 embryos/condition) were dissected and lysed in lysis buffer as described 
above. Lysates were then incubated with beads coupled to anti-Rab7 (ab77993, Abcam) or 
IgG control (ab37415, Abcam) antibodies for 30 minutes at 4°C. Beads were washed three 
times with lysis buffer and samples were eluted from the beads with 1x SDS sample buffer 
for 5 minutes at 95°C for protein and subsequent Western blot analysis. 
 
Quantitative PCR 
RNA was isolated from eluted samples using the RNeasy Mini kit (Qiagen) and reverse 
transcribed into cDNA using random hexamers and the SuperScript III First-Strand Synthesis 
System (ThermoFisher Scientific). The cDNA was used to prepare triplicate reactions for 
qPCR according to manufacturer’s instructions (QuantiTect SYBR Green PCR kit, Qiagen) 
and plates were centrifuged shortly and run on a LightCycler 480 (Roche) using the following 
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PCR conditions: denaturation for 15s at 94°C; annealing for 30s at 60°C; extension for 30s at 
72°C. The levels for each condition were corrected with their own input. The following 
primers were used for qPCR: for β-actin, 5’-CCAGAAGAACACCCAGTGCT-3’ and 5’-
CAGGGACAACACAGCTTGGA-3’; for lmnb2, 5’-GCAAGTGAAGATGTACAAGGAAGAA-3’ 
and 5’-CGTCGCTCAGTTAATTCTTCTAGGG-3’; for vdac2, 5’-
ACTCGCATGCAGCCATATCT-3’ and 5’-TACCAGCGCAGAAAGTGTGA-3’. 
 
Western Blot 
Proteins were resolved by SDS-PAGE on NuPage 4-12% Bis-Tris gels (ThermoFisher 
Scientific) and transferred to nitrocellulose membrane (Bio-Rad). The blots were blocked in 
milk for 45 minutes at room temperature and then incubated with primary antibodies in milk 
overnight at 4°C. After washing 3 times with TBS-T the blots were incubated with HRP-
conjugated secondary antibodies for 1 hour at RT, washed again for 3 times in TBS-T, 
followed by ECL-based detection (Pierce ECL plus, ThermoFisher Scientific). The following 
primary antibodies were used for Western blot analysis: rabbit anti-Rab7 (ab137029, 
Abcam), rabbit anti-Rpl10A (16681-1-AP, Proteintech), mouse anti-Rps3A (ab194670, 
Abcam), mouse anti-FXR (gift from Dr. Khandjian), rabbit anti-SFPQ (ab38148, Abcam), 
rabbit anti-Vg1RBP (gift from Dr. Standart), rabbit anti-mTOR (#2983, Cell Signaling). 
 
Immunohistochemistry  
Retinal cultures were fixed in 2% formaldehyde/7.5% sucrose in PBS for 20 minutes at 20°C. 
Antigen retrieval by steaming the fixed cultures in 0.01M sodium citrate (0.05% Tween, pH 
6.0) for 10 minutes was carried out before staining for phospho-AKT (Ser473), phospho-
mTOR (Ser2448) and phospho-S6 (Ser235/236). The cultures were then permeabilized for 
3-5 minutes in 0.1% Triton in PBS, or 25 minutes in 0.1% Saponin (for LAMP-1 staining) and 
blocked with 5% heat-inactivated goat serum in PBS for 30 minutes at 20°C. Primary 
antibodies were incubated overnight, followed by Alexa Fluor-conjugated secondary 
antibodies for 45 minutes at 20°C in dark. Cultures were mounted in FluorSave (Calbiochem) 
or Vectashield (Vector Laboratory) for super-resolution microscopy. Antibodies were used at 
the following dilutions. 1:200 rabbit anti-RPS3A (14123-1-AP, Proteintech), 1:200 mouse 
anti-RPS3A (ab194670, Abcam), 1:200 mouse anti-RPL19 (ab58328, Abcam), 1:200 rabbit 
anti-RPL24 (17082-1-AP, Proteintech), 1:400 rabbit anti-Vg1RBP (gift from Dr. Standart), 
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1:250 rabbit anti-LAMP-1 (ab24170, Abcam), 1:400 mouse anti-FXR (gift from Dr. 
Khandjian), 1:50 mouse anti-Rab5 (sc-46692, Santa Cruz), 1:300 rabbit anti-Rab7 
(ab137029, Abcam), 1:50 mouse anti-GM130 (BD610822, BD Biosciences), rabbit anti-
Rpl10A (16681-1-AP, Proteintech), 1:100 rabbit anti-phospho-AKT (Ser473) (9271T, Cell 
Signaling), 1:200 rabbit anti-phospho-mTOR (Ser2448) (ab109268, Abcam), 1:200 rabbit 
anti-mTOR (#2983, Cell Signaling), 1:800 rabbit anti-phospho-S6 Ribosomal Protein 
(Ser235/236) (#2211, Cell Signaling), 1:200 rabbit anti-SFPQ (ab38148, Abcam). Secondary 
antibodies: 1:500 goat anti-mouse/rabbit Alexa Fluor 488 (ThermoFisher Scientific) or 1:500 
goat anti-mouse rabbit Alexa Fluor 568 (ThermoFisher Scientific), except 1:1600 goat anti-
rabbit Alexa Fluor 568 for phospho-S6, 1:1000 goat anti-rabbit Alexa Fluor 568 
(ThermoFisher Scientific) for SFPQ immunohistochemistry. 
 
Molecular Beacon Live Imaging 
To visualize endogenous β-actin mRNA in Xenopus laevis RGC axons, two molecular 
beacons (MBs) were designed to target predicted single stranded regions in β-actin mRNA 
(Turner-Bridger et al., 2018). Briefly, the MBs were made of nuclease-resistant nucleotides 
which were either LNA (+N) or 2′-O-methyl RNA (oN) bases, ending with Cy3:BHQ-2TM 
fluorophore:quencher pair combination. Probe sequences were: MB1 Cy3-
oCoGoAoCoGoCoU+CoAoGoUoU+AoGoG+AoUoUoUoUoC+AoUoGoCoGoUoCoG-BHQ2; 
MB2 Cy3-oGoCoGoCoAoG+GoAoA+GoCoCoAoA+GoAoUoG+GoAoUoGoCoGoC-BHQ2. 
MB1 and MB2 were electroporated at a concentration of 25μM into stage 28 eye primordia 
together with either GFP-Rab5a or GFP-Rab7a in vitro transcribed mRNA (1μg μl-1). Eyes 
were dissected and cultured when Xenopus embryos reached stage 32, and RGC axons 
imaged the next day. Images were acquired on an Olympus IX81 inverted microscope that 
was fitted with a PerkinElmer Spinning Disk UltraVIEW VoX using a 100x oil immersion 
objective (1.4 N.A., Nikon), and an ORCA-Flash4.0 V2 CMOS camera (Hamamatsu). 
Volocity 6.3.0 software (PerkinElmer) was used for acquisition. Images were acquired at a 
frame rate of 1.5 seconds for 30 seconds. β-actin mRNA and either GFP-Rab5a or GFP-
Rab7a were classed as associated if the signal from the GFP (488nm laser line) and MB-Cy3 
(561nm laser line) channels merged, and remained merged for the duration of the movie, or 
until one of the puncta bleached (minimum 5 frames). To avoid bias in the degree of 
observed association due to variable levels of either MBs or GFP-Rabs proteins in axons, 
which was introduced by electroporation, we analyzed colocalization within 25 μm sections of 
axons that contained 0.8:1.5 ratio of MB:GFP-Rabs puncta. Associated puncta were defined 
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as “oscillatory,” if they remained within a 2 μm radius for the duration of the movie, or as 
“moving,” if the total distance travelled was greater than 2 μm. 
 
Axon-only Puromycin Labeling Assay 
After 48 hours, axons were severed from their cell bodies and subsequently treated with 10 
µg/ml puromycin (Sigma-Aldrich) for 10 minutes. After treatment, the cultures were fixed in 
2% formaldehyde/7.5% sucrose, permeabilized with 0.1% Triton (Sigma-Aldrich) and blocked 
in 5% heat-inactivated goat serum, then labeled with Alexa Fluor 647-conjugated mouse anti-
puromycin antibody (1:250, MABE343-AF647, Millipore) overnight. For experiments involving 
pharmacological treatments, axons were pre-treated with 50µM cycloheximide (Sigma-
Aldrich) for 20 minutes, 50µM dynasore (Sigma-Aldrich) for 20 minutes, 50µM Chloroquine 
(Sigma-Aldrich) or 2.5µM PP242 for 10 minutes before puromycin administration. 
 
Quantification of Immunofluorescence 
Randomly selected non-collapsed growth cones were imaged at 60x on a Nikon Eclipse 
TE2000-U inverted microscope equipped with an EMCCD camera. Exposure time was kept 
constant and below gray-scale pixel saturation. For quantitation of fluorescence intensity, the 
growth cone outline was traced on the phase contrast image using Volocity (PerkinElmer), 
then superimposed on the fluorescent image. The software calculated the fluorescent 
intensity within the growth cone, giving a measurement of pixel intensity per unit area. The 
growth cone outline was then placed in an adjacent area clear of cellular material to record 
the background fluorescent intensity. This reading was subtracted from the growth cone 
reading, yielding the background-corrected intensity. To plot the signal intensities, pixel 
fluorescent intensity across a line segment was measured in ImageJ. For colocalization test, 
Pearson’s correlation coefficient was obtained in ImageJ by using coloc2 plugin. Kymograph 
were obtained in ImageJ by using Multi kymograph plugin.   
 
SunTag-lmnb2 Imaging 
For SunTag-lmnb2 imaging, in vitro synthesized scFv-GFP and RFP-Rab7a mRNAs 
(200ng/µl) were injected (5nl) into each of the two dorsal blastomeres at 4-cell stage. When 
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the embryos developed to stage 26, Cy5-labeled SunTag-lmnb2 mRNA (1µg/µl) was 
electroporated into the retinal primordia. When the embryos reached stage 35/36, 
electroporated eyes were dissected and cultured. After 24 hours, continuous imaging of 
distal axons expressing in vitro synthesized scFv-GFP and RFP-Rab7a mRNAs was 
performed under a Perkin Elmer Spinning Disk UltraVIEW ERS, Olympus IX81 inverted 
microscope with a 100x oil objective and an ORCA-Flash4.0 camera (Hamamatsu) for 1 
minute. Exposure times were set between 50-500ms for each channel. Laser power of 488, 
559 and 640nm laser line was set to 10-30% of maximal intensity. Time-lapse images were 
recorded by Volocity software. In pharmacologically treated conditions, the retinal cultures 
were incubated with 100 µg/ml puromycin or 50µM chloroquine for 1h before imaging.   
 
Proximity Ligation Assay 
This experiment was carried out according to the manufacturer’s protocol (Duolink 
Biosciences) with specific modifications (Yoon et al., 2012). Eyes were severed from axonal 
explants after 48 h of outgrowth. Cultures were treated with 10µg/ml puromycin for 10 
minutes at RT, fixed in 2% formaldehyde/7.5% sucrose in PBS for 20 minutes at 20°C, 
washed 3 times in PBS + 0.001% Triton X-100, permeabilized for 3-5 minutes in 0.1% Triton 
X-100 in PBS, washed three times in PBS, blocked with 5% heat-inactivated goat or horse 
serum in PBS for 30 minutes at RT and subsequently incubated with primary antibodies 
overnight at 4°C. Primary antibodies were diluted at 1:500 for unconjugated mouse anti-
puromycin (MABE343, Millipore), 1:200 for rabbit anti-Lamin B2 (ab97513, Abcam) and 
1:500 for goat anti-VDAC2 (ab37985, Abcam). Dishes were washed twice for 5 minutes with 
0.002% Triton X-100 in PBS and incubated with anti-rabbit (+) or anti-goat (+) and anti-
mouse (-) PLA probes for 1 hour at 37°C, with ligase for 30 minutes at 37°C and with the 
polymerase mix with red fluorescence for 100 min at 37°C. The samples were subsequently 
mounted with the mounting medium (DUO82040, Duolink) and imaged using a Nikon Eclipse 
TE2000-U inverted microscope equipped with an EMCCD camera. The number of discrete 
fluorescent puncta within a randomly chosen 20µm axon segment in each image was 
counted using Volocity. 
 
OMX Super-resolution Microscopy 
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Super-resolution 3D SIM images were acquired using a Deltavision OMX 3D SIM System V3 
from Applied Precision (a GE Healthcare company) equipped with 3 EMCCD Cascade 
cameras from Photometrics, 488nm and 592.5 nm diode laser illumination, an Olympus 
PlanSApo 100× 1.40 NA oil objective, and standard excitation and emission filter sets. 
Imaging of each channel was performed sequentially using three angles and five phase shifts 
of the illumination pattern as described (Gustafsson et al., 2008). The refractive index of the 
immersion oil (Cargille) was adjusted to 1.513 to minimize spherical aberrations. Sections 
were acquired at 0.1μm z steps. Raw OMX data were reconstructed and channel registered 
in the SoftWoRx software (Applied Precision, a GE Healthcare company). Reconstructions 
were carried out using channel-specific Optical Transfer Functions (OTFs) and channel-
specific K0 angles. OTFs were generated within the SoftWoRx software by imaging 100 nm 
beads (Life Technologies) using appropriate immersion oils to match the data. Channel 
registration was carried out using the Image Registration parameters generated within the 
SoftWoRx software and checked for accuracy by imaging Tetraspeck beads (Life 
Technologies). Channel registration was accurate to one pixel. Further data analysis was 
performed using Fiji.  
 
Retinal Projection Visualization and Analysis 
Anaesthetized embryos of either sex were fixed at stage 39 or 45 in 4% formaldehyde in 
PBS at 4°C overnight and washed 3 times with filtered PBS. RGC axons of one eye per 
embryo were labeled by intraocular injection of fluorescent lipophilic dye, DiI (ThermoFisher 
Scientific). Embryos were left in PBS for 48 hours allowing the diffusion of the dye into the 
optic tract. The contralateral (or non-dye injected side) brain hemisphere was later dissected, 
mounted in PBS and visualized using confocal under 559nm laser line. Brains with less than 
30 visible axons were categorized as defective axonal projection phenotypes. For single-
blastomere injection experiments, axonal projections were analyzed by using Volocity 
automated detection of the fluorescence signal, creating a 3D mask matching the signal and 
providing the corresponding volume.   
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
All experiments were performed in at least three independent biological replicates. The n 
number for each experiment, details of statistical analysis and software are described in the 
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figure legends or main text. Statistical analyses used in this study include Wilcoxon Ranksum 
Test, Mann-Whitney test and Fisher’s exact Test. Statistical significance is defined as, n.s., 
not significant, *P<0.05, **P<0.01, ***P<0.001. Statistical analysis was performed using 
Prism (GraphPad) or MATLAB (MathWorks). 
 
Supplemental Movie Titles 
Movie S1. Association of Cy3-RNA granules with GFP-Rab5a- or GFP-Rab7a-
endosomes, Related to Figure 1  
Movie S2. Association of RPS3A-GFP with GFP-Rab5a- or GFP-Rab7a-endosomes, 
Related to Figure 2  
Movie S3. Association of GFP-Vg1RBP with RFP-Rab5a- or RFP-Rab7a-endosomes, 
Related to Figure 2 
Movie S4. Cy3-RNA granules associated with GFP-Rab7a-endosomes in contact with 
mitochondria, Related to Figure 4 
Movie S5. Axonal synthesis of LaminB2 on Rab7a-endosome visualized by SunTag 
fluorescent tagging system, Related to Figure 6  
 KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit polyclonal anti-RPS3A Proteintech Cat#14123-1-AP 
Mouse polyclonal anti-RPS3A Abcam Cat#ab194670 
Mouse polyclonal anti-RPL19 Abcam Cat#ab58328 
Rabbit polyclonal anti-RPL24 Proteintech Cat#17082-1-AP 
Rabbit polyclonal anti-Vg1RBP Gift from Dr Nancy 
Standart, Cambridge 
N/A 
Rabbit polyclonal anti-LAMP-1 Abcam Cat#ab24170 
Mouse monoclonal anti-FXR Gift from Dr Edward 
Khandjian, University 
of Quebec 
N/A 
Mouse monoclonal anti-Rab5 Santa Cruz Cat#sc-46692 
Rabbit monoclonal anti-Rab7 Abcam Cat#ab137029 
Rabbit polyclonal anti-Rab7 Abcam Cat#ab77993 
Mouse monoclonal anti-GFP Abcam Cat#ab1218 
Rabbit IgG, polyclonal, Isotype control Abcam Cat#ab37415 
Mouse monoclonal anti-GM130 BD Biosciences Cat#BD610822 
Rabbit polyclonal anti-RPL10A Proteintech Cat#16681-1-AP 
Rabbit polyclonal anti-phospho-AKT (Ser473) Cell Signaling Cat#9271T 
Rabbit monoclonal anti-phospho-mTOR (Ser2448) Abcam Cat#ab109268 
Rabbit monoclonal anti-mTOR Cell Signaling Cat#2983 
Rabbit polyclonal anti-phospho-S6 Ribosomal Protein 
(Ser235/236) 
Cell Signaling Cat#2211 
Mouse monoclonal anti-puromycin, clone 12D10 Sigma-Aldrich Cat#MABE343 
Mouse monoclonal anti-puromycin, clone 12D10, Alexa 
Fluor 647 Conjugate 
Sigma-Aldrich Cat#MABE343-
AF647 
Rabbit polyclonal anti-SFPQ Abcam Cat#ab38148 
Rabbit polyclonal anti-Lamin B2 Abcam Cat#ab97513 
Goat polyclonal anti-VDAC2 Abcam Cat#ab37985 
Goat anti-mouse Alexa Fluor 488 ThermoFisher 
Scientific 
Cat#A-11001 
Goat anti-mouse Alexa Fluor 568 ThermoFisher 
Scientific 
Cat#A-11004 
Goat anti-rabbit Alexa Fluor 488 ThermoFisher 
Scientific 
Cat#A-11008 
Goat anti-rabbit Alexa Fluor 568 ThermoFisher 
Scientific 
Cat#A-11011 
Bacterial and Virus Strains  
BioBlue Chemically Competent Cells Bioline Cat#BIO-85037 
Chemicals, Peptides, and Recombinant Proteins 
Leibovitz’s L-15 Medium ThermoFisher Cat#11415064 
Antibiotic-Antimycotic (100X) ThermoFisher Cat#15240062 
Poly-L-lysine Sigma-Aldrich Cat#P1274 
Laminin Sigma-Aldrich Cat#L2020 
Cy3-UTP PerkinElmer Cat#NEL582001EA 
Cy5-UTP PerkinElmer Cat#NEL583001EA 
Puromycin Sigma-Aldrich Cat#P8833 
Key Resource Table
 Cycloheximide Sigma-Aldrich Cat#C4859 
Dynasore Sigma-Aldrich Cat#D7693 
Chloroquine Sigma-Aldrich Cat#C6628 
PP242 Tocris Cat#4257 
SUPERase In RNase Inhibitor Ambion Cat#AM2696 
MitoTracker Deep Red FM ThermoFisher 
Scientific 
Cat#M22426 
LysoTracker Red CMXRos ThermoFisher 
Scientific 
Cat#M7512 
ER-Tracker Green ThermoFisher 
Scientific 
Cat#E34251 
1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine 
Perchlorate (Dil) 
ThermoFisher 
Scientific 
Cat#D282 
Tetramethylrhodamine, methyl ester (TMRM) ThermoFisher 
Scientific 
Cat#T668 
FluorSave Merck Millipore 
(Calbiochem) 
Cat#345789-20 
Vectashield mounting medium with DAPI Vector Laboratories Cat#H-1200 
Critical Commercial Assays 
SuperScript III First-Strand Synthesis System ThermoFisher 
Scientific 
Cat#18080051 
QuantiTect SYBR Green PCR kit Qiagen Cat#204141 
QuikChange II Site-Directed Mutagenesis Kit Agilent Technologies Cat#200555 
mMessage mMachine SP6 Transcription Kit ThermoFisher 
Scientific 
Cat#AM1340 
Poly(A) Tailing Kit ThermoFisher 
Scientific 
Cat#AM1350 
RNeasy Mini Kit Qiagen Cat#74104 
Duolink In Situ PLA Probe Anti-Rabbit PLUS Affinity 
purified Donkey anti- Rabbit IgG 
Sigma-Aldrich Cat#DUO92002 
Duolink In Situ PLA Probe Anti-Goat PLUS Affinity 
purified Donkey anti- Goat IgG 
Sigma-Aldrich Cat#DUO92003 
Duolink In Situ PLA Probe Anti-Mouse MINUS Affinity 
purified Donkey anti-Mouse IgG 
Sigma-Aldrich Cat#DUO92004 
Duolink In Situ Detection Reagents Red Sigma-Aldrich Cat#DUO92008 
Dynabeads Antibody Coupling kit Invitrogen Cat#14311D 
Experimental Models: Organisms/Strains 
Xenopus laevis Nasco Cat#LM00715, 
Cat#LM00535 
Oligonucleotides 
Molecular beacon: MB1 Cy3-
oCoGoAoCoGoCoU+CoAoGoUoU+AoGoG+AoUoUoUo
UoC+AoUoGoCoGoUoCoG-BHQ2 
(Turner-Bridger et al., 
2018) 
N/A 
Molecular beacon: MB2 Cy3-
oGoCoGoCoAoG+GoAoA+GoCoCoAoA+GoAoUoG+Go
AoUoGoCoGoC-BHQ2 
(Turner-Bridger et al., 
2018) 
N/A 
Primers for actb (Xenopus laevis) qRT-PCR forward:  
5’-CCAGAAGAACACCCAGTGCT-3’ 
This study N/A 
Primers for actb (Xenopus laevis) qRT-PCR reverse: 
5’-CAGGGACAACACAGCTTGGA-3’ 
This study N/A 
 Primers for lmnb2 (Xenopus laevis) qRT-PCR forward:  
5’-GCAAGTGAAGATGTACAAGGAAGAA-3’ 
This study N/A 
Primers for lmnb2 (Xenopus laevis) qRT-PCR reverse: 
5’-CGTCGCTCAGTTAATTCTTCTAGGG-3’ 
This study N/A 
Primers for vdac2 (Xenopus laevis) qRT-PCR forward:  
5’-ACTCGCATGCAGCCATATCT-3’ 
This study N/A 
Primers for vdac2 (Xenopus laevis) qRT-PCR reverse: 
5’-TACCAGCGCAGAAAGTGTGA-3’ 
This study N/A 
Recombinant DNA 
Plasmid: pCS2+-GFP (Das et al., 2003) N/A 
Plasmid: pCS2+-GFP-Rab5a (Xenopus laevis) (Falk et al., 2014) N/A 
Plasmid: pCS2+-RFP-Rab5a (Xenopus laevis) (Falk et al., 2014) N/A 
Plasmid: pCS2+-GFP-Rab7a (Xenopus laevis) (Falk et al., 2014) N/A 
Plasmid: pCS2+-RFP-Rab7a (Xenopus laevis) (Falk et al., 2014) N/A 
Plasmid: pCS2+-GFP-Rab5aQ80L (Xenopus laevis) This study N/A 
Plasmid: pCS2+-GFP-Rab5aS35N (Xenopus laevis) This study N/A 
Plasmid: pCS2+-GFP-Rab7aQ67L (Xenopus laevis) (Falk et al., 2014) N/A 
Plasmid: pCS2+-GFP-Rab7aT22N (Xenopus laevis) (Falk et al., 2014) N/A 
Plasmid: pCS2+-GFP-Rab7aL129F (Xenopus laevis) This study N/A 
Plasmid: pCS2+-GFP-Rab7aK157N (Xenopus laevis) This study N/A 
Plasmid: pCS2+-GFP-Rab7aN161T (Xenopus laevis) This study N/A 
Plasmid: pCS2+-GFP-Rab7aV162M (Xenopus laevis) This study N/A 
Plasmid: pCS2+-RFP-Rab7aN161T (Xenopus laevis) This study N/A 
Plasmid: pCS2+-RFP-Rab7aV162M (Xenopus laevis) This study N/A 
Plasmid: pCS2+-Lamp1-RFP (Sherer et al., 2003) Re-cloned from 
Addgene Cat#1817 
Plasmid: pCS2+-Rps3a-GFP (Xenopus laevis) This study N/A 
Plasmid: pCS2+-Rps4x-GFP (Xenopus laevis) This study N/A 
Plasmid: pCS2+-GFP-Vg1RBP (Leung et al., 2006) N/A 
Plasmid: Mito-GFP Gift from Dr Michael 
Coleman, Cambridge 
N/A 
Plasmid: pCS2+-lmnb2 5’UTR-24xSunTag-lmnb2 CDS-
lmnb2 
(Klein et al., 2002; Yan 
et al., 2016) 
Re-cloned from 
Source Bioscience 
SB5157193 (lmnb2); 
Addgene Cat#74928 
(24xSunTag) 
Plasmid: pCS2+-scFv-sfGFP (Tanenbaum et al., 
2014) 
Re-cloned from 
Addgene Cat#60907 
Software and Algorithms 
Volocity PerkinElmer Version 6.0.1, 
RRID:SCR_002668 
FIJI (Schindelin et al., 
2012) 
Version 2.0.0-rc-
65/1.51w, 
RRID:SCR_002285 
MATLAB MathWorks Version R2016b, 
RRID:SCR_001622 
GraphPad Prism GraphPad Version 5, 
RRID:SCR_002798 
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